Cessation

Ref: 18/SE/LC/2026-27 Date: July 13, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400 001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400 051 Sub.: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In reference to our earlier intimation dated June 26, 2026, bearing reference no. 16/SE/LC/2026-27 and in pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions, this is to inform you that vide email dated July 13, 2026, Mr. Rajesh Shashikant Dalal (DIN: 03504969), has informed the Board of Directors of the Company of his decision not to seek re-appointment as Non-Executive Independent Director for second term on completion of his first term on August 24, 2026. Copy of his email dated July 13, 2026, is enclosed herewith as required. Accordingly, Mr. Rajesh Shashikant Dalal shall cease to be a Non-Executive Independent Director of the Company and shall also cease to be the Chairperson of the Nomination and Remuneration Committee and the Stakeholders Relationship Committee, and the member of the Audit Committee of the Board, with effect from the close of business hours on August 24, 2026. The details required to be furnished in compliance with Regulation 30 read with Part A of Schedule III of the SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026, as amended, are enclosed as Annexure-A. The above information will also be available on the website of the Company at www.enterohealthcare.com You are requested to take the same on record. Yours faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice President - Group General Counsel, Company Secretary & Compliance Officer Encl: as above Annexure – A Details in terms of Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 Particulars Details Reason for change viz. appointment, re- Mr. Rajesh Shashikant Dalal (DIN: 03504969) has appointment, resignation, removal, death or informed the Board of Directors of the Company of his otherwise decision not to seek re-appointment as a Non- Executive Independent Director for the second term on completion of his first term on August 24, 2026 Date of appointment/re-appointment/ cessation (as August 24, 2026 applicable) & term of appointment/re-appointment; Brief Profile (in case of appointment) Not Applicable Disclosure of relationships between Directors (in Not Applicable case of appointment of a Director) Information as required pursuant to BSE Circular Not Applicable with ref. no. LIST/COMP/14/2018-19 and the National Stock Exchange of India Limited Circular with ref. no. NSE/CML/2018/ 24, both dated 20 June 2018 Sanu Kapoor From: Rajesh Dalal <dalal.rajesh@incina.com> Sent: Monday, July 13, 2026 1:36 PM To: Arun Sadhanandham; Chakraborty, Sumona; Prabhat Agrawal; Prem Sethi; Sandhya Gadkari Sharma; sujesh vasudevan Cc: Sanu Kapoor Subject: Board position CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe. Hello Entero Board My term as Independent Director with Entero will end on 24 August 2026 I would like to convey to the Entero Board that I would not like to be reelected to the board at the end of my term Kindly process this with relevant authorities and let me have confirmation that my term will not be extended and that I am no more on the board of entero Many thanks Rajesh Dalal Rajesh Dalal Incina Consultants